Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer

Clinical trial NCT07538258 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07538258
Sponsor: Yayi He
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Limited-stage Small Cell Lung Cancer (LS-SCLC)

Start date: 2026-04-20
Primary completion: 2027-09-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.